Detalhe da pesquisa
1.
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 28(9): 812-822, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011230
2.
Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma.
Oncologist
; 25(5): 438-446, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048768
3.
Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
J Am Acad Dermatol
; 84(1): 183-185, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334053
4.
Comparing the associations between host and tumor factors with survival outcomes with anti-PD-1 immunotherapy in metastatic melanoma.
Cancer Med
; 12(3): 2427-2439, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924450
5.
Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort.
J Can Assoc Gastroenterol
; 5(1): 39-47, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118226
6.
The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.
Cancers (Basel)
; 11(11)2019 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31684111
7.
Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer.
Oncotarget
; 9(9): 8573-8583, 2018 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492218
8.
Outcomes and Drug Costs of Sunitinib Regimens for Metastatic Renal Cell Carcinoma: A Provincial Population-Based Study.
Clin Genitourin Cancer
; 15(3): e397-e404, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28216279
9.
Neurotoxic overdose in a young man: question and answer.
J Clin Neurosci
; 23: 129, 170, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27088143
10.
Neurotoxic overdose in a young man: answer.
J Clin Neurosci
; 23: 170, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27090922